Floatz logo

Icapamespib

Grade 3 Isocitrate Dehydrogenase (IDH) Wildtype Astrocytoma

Samus Therapeutics, Inc.Small moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Grade 3 Isocitrate Dehydrogenase (IDH) Wildtype Astrocytoma cohort.

Asset / SponsorPhaseRating
wsd0922-fu
Mayo Clinic
Phase 1NR

Same molecule, other indications

Icapamespib is also rated in:

glioblastomaDormant
CC
Indicative ·
43 / 100
View asset →
high grade astrocytic tumorDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →